The Past, Present and Future of Heart Transplantation
Korean Circulation Journal
; : 565-590, 2018.
Article
en En
| WPRIM
| ID: wpr-917155
Biblioteca responsable:
WPRO
ABSTRACT
Heart transplantation (HTx) has become standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-HTx care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of HTx recipients. However, limitations to long-term allograft survival exist, including rejection, infection, coronary allograft vasculopathy, and malignancy. Careful balance of immunosuppressive therapy and vigilant surveillance for complications can further improve long-term outcomes of HTx recipients.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
En
Revista:
Korean Circulation Journal
Año:
2018
Tipo del documento:
Article